Jonathan Smith, one of the co-founders of AlphaVax, is the firm’s new chief science officer.

Smith, who has a PhD, has been the vice president of discovery for three years. He now will be responsible for research and development as well.

AlphaVax is seeking new vaccine technology to fight infectious diseases and cancer. The first human clinical trials are underway.

Smith was a vaccinologist at the United States Army Medical Research Institute of Infectious Diseases, heading the viral biology department, before joining AlphaVax.